Opioid Growth Factor (OGF) and Gemcitabine: Novel Treatment for Pancreatic Cancer
Clinical trial NCT00783172 · TERMINATED
Trial details
- NCT number
- NCT00783172
- Sponsor
- Milton S. Hershey Medical Center
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-01-01
- Primary completion
- 2010-08-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.